Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis

被引:9
|
作者
Tong, Huan [1 ]
Gan, Can [2 ]
Wei, Bo [1 ]
Wang, Zhi Dong [1 ]
Li, Xiao Dan [1 ]
Qian, Shuai Jie [2 ]
Huan, Hui [2 ]
Zhang, Lin Hao [1 ]
Yang, Zhu [2 ]
Chen, Yi Long [3 ,4 ]
Gu, Yong Hong [3 ,4 ]
Chen, Liu Xiang [2 ]
Yang, Yu Hang [2 ]
Wu, Hao [1 ]
Tang, Cheng Wei [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Gastroenterol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Sch Med, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Sch Med, West China Biomed Big Data Ctr, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, Med Big Data Ctr, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatic encephalopathy; liver cirrhosis; transjugular intrahepatic portosystemic shunt; risk factor; PORTAL-HYPERTENSION; AMMONIA LEVELS; BLOOD AMMONIA; TIPS; MANAGEMENT; HYDROTHORAX; ASSOCIATION; GUIDELINES; CONSENSUS; WORKSHOP;
D O I
10.1111/1751-2980.12957
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective This study aimed to determine the risk factors and establish a risk score for post-transjugular intrahepatic portosystemic shunt (TIPS) overt hepatic encephalopathy (OHE). Methods Altogether 299 and 62 cirrhotic patients receiving TIPS from January 2015 to March 2018 were divided into the derivation and validation cohorts, respectively. The data of the derivation cohort were analyzed for risk factors of post-TIPS OHE. A risk score was established from the derivation cohort and verified by the validation cohort. Results During a median follow-up of 112.6 weeks, 52 (17.4%) patients in the derivation cohort experienced post-TIPS OHE. Logistic regression showed that alcoholic cirrhosis (odds ratio [OR] 3.068, 95% confidence interval [CI] 1.423-6.613, P = 0.004), stent diameter of 10 mm (OR 12.046 [95% CI 2.308-62.862], P = 0.003), portal pressure gradient (PPG) decrement >= 60% (OR 3.548 [95% CI 1.741-7.230], P < 0.001), model for end-stage liver disease (MELD) score >= 10 (OR 2.695 [95% CI 1.203-6.035], P = 0.016), blood ammonia (OR 1.009 [95% CI 1.000-1.018], P = 0.043) and notable hydrothorax (OR 4.393 [95% CI 1.554-12.415], P = 0.005) were associated with an increased risk of post-TIPS OHE. The risk score reached a promising risk evaluation of post-TIPS OHE when verified by the validation cohort (sensitivity 71.4%, specificity 70.7%, accuracy 71.0%). Conclusions Alcoholic cirrhosis and notable hydrothorax are independent risk factors for post-TIPS OHE in liver cirrhosis, together with the stent diameter of 10 mm, PPG decrement >= 60%, MELD score >= 10 and blood ammonia. The established risk score is reliable to identify high-risk individuals of developing post-TIPS OHE.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [21] Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients
    Gou, Xiaoyuan
    Jia, Wenyuan
    He, Chuangye
    Yuan, Xulong
    Niu, Jing
    Xu, Jiao
    Han, Na
    Zhu, Ying
    Wang, Wenlan
    Tie, Jun
    EUROPEAN RADIOLOGY, 2023, 33 (05) : 3407 - 3415
  • [22] A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients
    Yin, Xiaochun
    Zhang, Feng
    Guo, Huiwen
    Peng, Chunyan
    Zhang, Wei
    Xiao, Jiangqiang
    Wang, Yi
    Zou, Xiaoping
    Zhang, Ming
    Zhuge, Yuzheng
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with variceal hemorrhage
    Khien Vu
    Duong Minh Thang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 264 - 264
  • [24] Unique Method of Transjugular Intrahepatic Portosystemic Shunt Reduction for Refractory Hepatic Encephalopathy
    Khan, Ayub
    Bailey, Christopher W.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [25] Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
    Yang, Chongtu
    Liu, Jiacheng
    Shi, Qin
    Huang, Songjiang
    Zhou, Chen
    Wang, Yingliang
    Li, Tongqiang
    Chen, Yang
    Xiong, Bin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (10) : 2893 - 2902
  • [26] Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and post-transjugular intrahepatic portosystemic shunt complications in 2020
    Horhat, Adelina
    Bureau, Christophe
    Thabut, Dominique
    Rudler, Marika
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (02) : 203 - 208
  • [27] Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation
    Jahangiri, Younes
    Kerrigan, Timothy
    Li, Lei
    Prosser, Dominik
    Brar, Anantnoor
    Righetti, Johnathan
    Schenning, Ryan C.
    Kaufman, John A.
    Farsad, Khashayar
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 : S150 - S158
  • [28] Critical Flicker Frequency as a Marker of Hepatic Encephalopathy in Patients before and after Transjugular Intrahepatic Portosystemic Shunt
    Biecker, Erwin
    Hausdoerfer, Iris
    Gruenhage, Frank
    Strunk, Holger
    Sauerbruch, Tilman
    DIGESTION, 2011, 83 (1-2) : 24 - 31
  • [29] Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt
    Yang, Yang
    Liang, Xueqing
    Yang, Shirui
    He, Xiaofeng
    Huang, Mingsheng
    Shi, Wenfeng
    Luo, Junyang
    Duan, Chongyang
    Feng, Xinghui
    Fu, Sirui
    Lu, Ligong
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
  • [30] Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision
    Michael W. Rowley
    Myunghan Choi
    Steve Chen
    Kevin Hirsch
    Anil B. Seetharam
    CardioVascular and Interventional Radiology, 2018, 41 : 1765 - 1772